Position in VRTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$6,916,904
-$1,079,459 QoQ
Shares Held
15,490
-12.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
3.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 6.7462879276952865.ToString("F0")%
Shared 0.ToString("F0")%
None 93.25371207230472.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NIA IMPACT ADVISORS, LLC holds $8,978,576 across 2 Biotechnology names. VRTX ranks #1 (77.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
15,490 | $6,916,904 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
268,797 | $2,061,672 |
All Filings in VRTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,916,904 | 15,490 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,996,363 | 17,638 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,240,000 | 15,933 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,072,892 | 15,887 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,724,152 | 15,932 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,415,816 | 15,932 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,058,441 | 17,327 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,802,092 | 18,779 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,258,623 | 19,757 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $7,054,387 | 20,046 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,372,605 | 20,226 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $5,537,356 | 19,175 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,966,190 | 17,152 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,146,958 | 7,619 | Shares | Sole | 2022-08-05 | |
| No filing history on record for this holder in this stock. | ||||||